HIGHLIGHTS
- who: Tiziana Feola and colleagues from the Neuromed IRCCS, Pozzilli, Italy Department Experimental Medicine, La Sapienza University Rome, Rome, Italy have published the research work: Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art, in the Journal: (JOURNAL)
- what: The aim of this study was to review in detail the individual characteristics of PitNETs treated by ICIs in light of the current literature, starting from the recent experience with a non-functioning met-PitNET derived from the Pit1 lineage.
SUMMARY
In PitNETs, the experience is yet limited . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.